NanoDev Therapeutics LLC (NanoDev) is a collaborative global research and commercialization platform focusing on expedited development of novel cancer drug discovery and implemented in clinical practice. Our member partners share and benefit from collaboration, shared intellectual property, global institutional resources, and commercialization.
NanoDev was founded by researchers and clinicians at leading research institutions collaborating with the founders of MNPHARM SBC. This strategic collaboration was formed as an accelerator for cancer drug discovery.
NanoDev Founders are associated with some of the top research
institutions in the world including Taipei Medical University (TMU) in
Taiwan, Council of Scientific and Industrial Research (CSIR), in India,
and the Mayo Clinic in Rochester, MN and Mayo Clinic in Jacksonville, FL USA.
Many founders of NanoDevTherapeutics LLC have patents issued in the field of cancer therapeutic development and offer expertise in the area of clinical trials. We are in the process of licensing a number of the patents associated with our membership.